RESBIOTIC, INC.

VESTAVIA HILLS, AL · Founded 2019 · CIK 0001850319 · Biotech · Private

Inhaled spray-dried powder biotherapeutic containing Lactobacillus strains to reduce neutrophilic inflammation in COPD

Grants
$295K
1 award
Sector median: 1
Raised
$1.6M
1 Form D · Mar 2021
67 months since last filing
Contracts
—
No federal contracts on record
Patents
1
0 granted · 1 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$1,600,000
Federal grantDepartment of Health and Human Services · Phase II · An Inhaled Microbiome-Targeted Biotherapeutic for Treatment of COPD$295,274
Federal grant · SBIR/STTRForm D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1470Up Therapeutics LLC——
1471CALIFORNIA STEM CELL INC—$1.9M
1472Aptorum Group Ltd—$1.6M
1473RESBIOTIC, INC.—$1.6M
1474UBIVAC, INC.—$1.5M
1475EXSCIEN CORPORATION——
1476SirnaMed Therapeutics Inc.—$1.3M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 2 related persons
  • Braxton GoodrichDirector
  • Charitharth LalDirector · Executive Officer

Patents

USPTO · 0 granted of 1
  • Probiotic Bacteria Mix And Herb-based Nutraceuticals For Lung Health Maintenanceapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.